Remed Co.,Ltd. (KOSDAQ:302550)

South Korea flag South Korea · Delayed Price · Currency is KRW
3,180.00
+5.00 (0.16%)
At close: Mar 6, 2026
3.25%
Market Cap 95.19B
Revenue (ttm) 24.26B
Net Income (ttm) 3.28B
Shares Out 30.91M
EPS (ttm) 103.55
PE Ratio 29.74
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 210,181
Average Volume 1,434,668
Open 3,150.00
Previous Close 3,175.00
Day's Range 3,090.00 - 3,275.00
52-Week Range 2,640.00 - 4,595.00
Beta 0.73
RSI 48.98
Earnings Date Mar 18, 2026

About Remed

Remed Co.,Ltd. engages in the manufacture and supply of medical devices worldwide. The company offers transcranial magnetic stimulator, a technology for the treatment of disorders, such as stroke, autism, dementia, Parkinson's disease, developmental disorders, and tinnitus. It also offers neuro magnetic stimulation systems for helping blood circulation, treating pain, neurons, regenerating cells, and contraction and relaxation of muscles, as well as core muscle strengthening magnetic stimulation to enable building toned and shaped muscles. In a... [Read more]

Industry Electromedical and Electrotherapeutic Apparatus
Founded 2003
Employees 92
Stock Exchange KOSDAQ
Ticker Symbol 302550
Full Company Profile

Financial Performance

In 2024, Remed's revenue was 25.55 billion, an increase of 37.86% compared to the previous year's 18.54 billion. Earnings were 7.17 billion, an increase of 799.69%.

Financial Statements

News

There is no news available yet.